WatchGov

New York bills · 2025 Regular Session

New York S 36

Relates to the labeling of mifepristone, misoprostol, and their generic alternatives

  1. Introduced
  2. In committee
  3. Passed Senate
  4. Passed House
  5. To Governor
  6. Became law

Sponsors

Cosponsors (5)

Summary

Official abstract published by the New York legislature

Permits prescription labels for mifepristone, misoprostol, and their generic alternatives to include the name of the prescribing health care practice instead of the name of the prescriber at the prescriber's request.

Text versions

Roll-call votes

State vote data last updated Oct 16, 2026, 8:07 AM.

DateVoteResultYour legislators
Jan 22, 2025
House
Assembly VotepassSet your home in New York to see
Jan 21, 2025
Senate
Floor Vote - Version: ApassSet your home in New York to see
Jan 21, 2025
Senate
Rules Vote - Version: ApassSet your home in New York to see

Actions